Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer.

Veneziani, Ana C; Scott, Clare; Wakefield, Matthew J; Tinker, Anna V; Lheureux, Stephanie

Veneziani, Ana C; Scott, Clare; Wakefield, Matthew J; Tinker, Anna V; Lheureux, Stephanie.

Afiliação

Veneziani AC; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Scott C; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Wakefield MJ; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Tinker AV; Royal Women's Hospital, Parkville, VIC, Australia.
Lheureux S; Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Ther Adv Med Oncol ; 15: 17588359231157644, 2023.

Article em En | MEDLINE | ID: mdl-36872947

Palavras-chave

PARP inhibitor; biomarkers; homologous recombination deficiency; ovarian cancer; replication stress

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google